https://www.drarsy.com/blogs/news/der-p1-der-p2-patch-36-eczema-allergy-vs-irritancy-study 2026-11-10T18:51:55-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/mite-29.jpg?v=1794365515 Der p 1 and Der p 2 Patch Tests in 36 Eczema Patients: Allergy Versus Irritancy AI-created editorial illustration for Der p 1 and Der p 2 Patch Tests in 36 Eczema Patients: Allergy Versus Irritancy; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/lip-eczema-cinnamon-flavor-gum-tea-contact-reaction 2026-11-11T00:28:06-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/exec-4b1b2080-cccc-489f-8cc2-c36d421d2fcb.png?v=1794368667 Lip Eczema and Cinnamon Flavor: Could Gum or Tea Irritate the Skin Around Your Mouth? AI-generated illustration of an adult discussing lip irritation with a dermatologist https://www.drarsy.com/blogs/news/occupational-contact-urticaria-815-finnish-cases 2026-11-10T19:54:20-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-01-finnish_ocu_815.png?v=1794369260 Occupational Contact Urticaria Across 815 Finnish Cases Dr. Arsy #003 Life in Motion editorial illustration: Occupational Contact Urticaria Across 815 Finnish Cases. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/eczema-itch-lesion-phenotypes-4433-us-costs-study 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-01.jpg?v=1794369262 Eczema Itch and Lesion Phenotypes: U.S. Costs in 4,433 People AI-created editorial illustration for Eczema Itch and Lesion Phenotypes: U.S. Costs in 4,433 People. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/latex-sensitization-1171-healthcare-other-workers 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-02-latex_1171.png?v=1794369263 Latex Sensitization in 1,171 Healthcare and Other Workers Dr. Arsy #003 Life in Motion editorial illustration: Latex Sensitization in 1,171 Healthcare and Other Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/occupational-contact-urticaria-143-1720-australian-patients 2026-11-10T19:54:26-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-03-australian_ocu_143.png?v=1794369266 Occupational Contact Urticaria in 143 of 1,720 Australian Patients Dr. Arsy #003 Life in Motion editorial illustration: Occupational Contact Urticaria in 143 of 1,720 Australian Patients. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/contact-dermatitis-432-north-american-hairdressers-cosmetologists 2026-11-10T19:54:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-04-hairdressers_432.png?v=1794369269 Contact Dermatitis in 432 North American Hairdressers and Cosmetologists Dr. Arsy #003 Life in Motion editorial illustration: Contact Dermatitis in 432 North American Hairdressers and Cosmetologists. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/hand-eczema-career-change-5324-danish-hairdressers 2026-11-10T19:54:32-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-06-hair_career_5324.png?v=1794369272 Hand Eczema and Career Change in 5,324 Danish Hairdressers Dr. Arsy #003 Life in Motion editorial illustration: Hand Eczema and Career Change in 5,324 Danish Hairdressers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/contact-dermatitis-87-car-repair-workers-76-controls 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-05-car_repair_87.png?v=1794369275 Contact Dermatitis in 87 Car-Repair Workers and 76 Controls Dr. Arsy #003 Life in Motion editorial illustration: Contact Dermatitis in 87 Car-Repair Workers and 76 Controls. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/adult-eczema-us-healthcare-costs-severity-linked-emr-claims 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-02.jpg?v=1794369277 Adult Eczema Healthcare Use and Costs by Severity in Linked U.S. Records AI-created editorial illustration for Adult Eczema Healthcare Use and Costs by Severity in Linked U.S. Records. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-eczema-direct-indirect-costs-31164-matched-study 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-03.jpg?v=1794369278 Direct and Indirect Costs of Adult Eczema: A 31,164-Person Matched Study AI-created editorial illustration for Direct and Indirect Costs of Adult Eczema: A 31,164-Person Matched Study. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/employment-sick-leave-8940-occupational-dermatitis-notifications 2026-11-10T19:54:38-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-07-employment_8940.png?v=1794369278 Employment and Sick Leave After 8,940 Occupational-Dermatitis Notifications Dr. Arsy #003 Life in Motion editorial illustration: Employment and Sick Leave After 8,940 Occupational-Dermatitis Notifications. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/child-eczema-caregiver-out-of-pocket-costs-1118-survey 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-06.jpg?v=1794369280 Caregiver Out-of-Pocket Costs for Childhood Eczema: A U.S. Survey AI-created editorial illustration for Caregiver Out-of-Pocket Costs for Childhood Eczema: A U.S. Survey. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/six-month-work-outcomes-78-workers-contact-dermatitis 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-08-rtw_78.png?v=1794369281 Six-Month Work Outcomes in 78 Workers With Contact Dermatitis Dr. Arsy #003 Life in Motion editorial illustration: Six-Month Work Outcomes in 78 Workers With Contact Dermatitis. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/child-eczema-under-six-23098-us-healthcare-costs 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-05.jpg?v=1794369281 U.S. Healthcare Costs for 23,098 Children Under Six With Eczema AI-created editorial illustration for U.S. Healthcare Costs for 23,098 Children Under Six With Eczema. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-eczema-119716-us-commercial-medicare-medicaid-costs 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-04.jpg?v=1794369283 Adult Eczema Costs Across U.S. Commercial, Medicare and Medicaid Data AI-created editorial illustration for Adult Eczema Costs Across U.S. Commercial, Medicare and Medicaid Data. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/testing-hand-dermatitis-questionnaire-224-rubber-workers 2026-11-10T19:54:45-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-10-rubber_questionnaire_224.png?v=1794369285 Testing a Hand-Dermatitis Questionnaire in 224 Rubber Workers Dr. Arsy #003 Life in Motion editorial illustration: Testing a Hand-Dermatitis Questionnaire in 224 Rubber Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/child-eczema-financial-emotional-impact-82-family-study 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-07.jpg?v=1794369286 Childhood Eczema’s Financial and Emotional Impact: An 82-Family Study AI-created editorial illustration for Childhood Eczema’s Financial and Emotional Impact: An 82-Family Study. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/return-to-work-outcomes-194-occupational-dermatitis-patients 2026-11-10T19:54:48-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-09-rtw_clinic_194.png?v=1794369288 Return-to-Work Outcomes in 194 Occupational-Dermatitis Patients Dr. Arsy #003 Life in Motion editorial illustration: Return-to-Work Outcomes in 194 Occupational-Dermatitis Patients. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/child-eczema-cost-illness-multiethnic-asian-study 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-08.jpg?v=1794369288 The Cost of Childhood Eczema in a Multiethnic Asian Population AI-created editorial illustration for The Cost of Childhood Eczema in a Multiethnic Asian Population. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/allergic-disease-head-registry-778-europe-economic-impact 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-10.jpg?v=1794369289 Economic Impact in the 778-Patient European HEAD Allergy Registry AI-created editorial illustration for Economic Impact in the 778-Patient European HEAD Allergy Registry. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/moderate-severe-eczema-europe-costs-societal-review 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-09.jpg?v=1794369291 Moderate-to-Severe Eczema Costs and Societal Impact Across Europe AI-created editorial illustration for Moderate-to-Severe Eczema Costs and Societal Impact Across Europe. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/contact-sensitization-3356-german-metalworkers 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-11-metalworkers_3356.png?v=1794369291 Contact Sensitization in 3,356 German Metalworkers Dr. Arsy #003 Life in Motion editorial illustration: Contact Sensitization in 3,356 German Metalworkers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/adult-adolescent-eczema-burden-233-study-systematic-review 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-11.jpg?v=1794369292 Adult and Adolescent Eczema Burden: A 233-Study Systematic Review AI-created editorial illustration for Adult and Adolescent Eczema Burden: A 233-Study Systematic Review. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/contact-urticaria-three-large-clinical-cohorts 2026-11-10T19:54:54-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-12-cu_three_cohorts.png?v=1794369294 Contact Urticaria Across Three Large Clinical Cohorts Dr. Arsy #003 Life in Motion editorial illustration: Contact Urticaria Across Three Large Clinical Cohorts. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/eczema-economic-impact-us-five-billion-review 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-12.jpg?v=1794369296 The Economic Impact of Eczema in the United States: An Evidence Review AI-created editorial illustration for The Economic Impact of Eczema in the United States: An Evidence Review. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-eczema-nhis-cost-access-workdays-61770-study 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-15.jpg?v=1794369297 Adult Eczema, Healthcare Access and Missed Workdays in 61,770 U.S. Adults AI-created editorial illustration for Adult Eczema, Healthcare Access and Missed Workdays in 61,770 U.S. Adults. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/occupational-contact-urticaria-trends-251-french-cases 2026-11-10T19:54:57-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-13-french_ocu_251.png?v=1794369297 Occupational Contact Urticaria Trends Across 251 French Cases Dr. Arsy #003 Life in Motion editorial illustration: Occupational Contact Urticaria Trends Across 251 French Cases. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/eczema-harmful-household-financial-impact-1118-us-survey 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-14.jpg?v=1794369299 When Eczema Costs Harm Household Finances: A 1,118-Person Survey AI-created editorial illustration for When Eczema Costs Harm Household Finances: A 1,118-Person Survey. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/eczema-out-of-pocket-expenses-1118-us-survey 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-13.jpg?v=1794369300 Out-of-Pocket Eczema Expenses: A 1,118-Person U.S. Survey AI-created editorial illustration for Out-of-Pocket Eczema Expenses: A 1,118-Person U.S. Survey. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/three-year-latex-follow-up-1040-healthcare-workers 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-14-powder_free_1040.png?v=1794369300 Three-Year Latex Follow-Up in 1,040 Healthcare Workers Dr. Arsy #003 Life in Motion editorial illustration: Three-Year Latex Follow-Up in 1,040 Healthcare Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/child-eczema-quality-life-healthcare-costs-cross-sectional 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-16.jpg?v=1794369302 Child Eczema Quality of Life and Healthcare Costs: A Cross-Sectional Study AI-created editorial illustration for Child Eczema Quality of Life and Healthcare Costs: A Cross-Sectional Study. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/work-ability-latex-exposure-controls-196-healthcare-workers 2026-11-10T19:55:03-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-15-latex_work_196.png?v=1794369303 Work Ability After Latex-Exposure Controls in 196 Healthcare Workers Dr. Arsy #003 Life in Motion editorial illustration: Work Ability After Latex-Exposure Controls in 196 Healthcare Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/adult-eczema-unmet-needs-work-daily-life-186-survey 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-17.jpg?v=1794369305 Adult Eczema Unmet Needs, Work and Daily Life: A 186-Person Survey AI-created editorial illustration for Adult Eczema Unmet Needs, Work and Daily Life: A 186-Person Survey. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/occupational-skin-disease-surveillance-336-saarland-cases 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-17-saarland_336.png?v=1794369306 Occupational Skin-Disease Surveillance Across 336 Saarland Cases Dr. Arsy #003 Life in Motion editorial illustration: Occupational Skin-Disease Surveillance Across 336 Saarland Cases. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/eczema-out-of-pocket-costs-nine-european-countries-1189 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-18.jpg?v=1794369307 Eczema Out-of-Pocket Costs Across Nine European Countries AI-created editorial illustration for Eczema Out-of-Pocket Costs Across Nine European Countries. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-eczema-france-out-of-pocket-costs-1024-cohort 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-19.jpg?v=1794369308 Adult Eczema Out-of-Pocket Costs in France: A 1,024-Person Cohort AI-created editorial illustration for Adult Eczema Out-of-Pocket Costs in France: A 1,024-Person Cohort. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/twelve-years-occupational-skin-disease-5265-finnish-cases 2026-11-10T19:55:09-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-16-finland_registry_5265.png?v=1794369309 Twelve Years of Occupational Skin Disease Across 5,265 Finnish Cases Dr. Arsy #003 Life in Motion editorial illustration: Twelve Years of Occupational Skin Disease Across 5,265 Finnish Cases. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/child-mild-moderate-eczema-sweden-87721-economic-burden 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-20.jpg?v=1794369310 Mild-to-Moderate Childhood Eczema in Sweden: An 87,721-Child Economic Study AI-created editorial illustration for Mild-to-Moderate Childhood Eczema in Sweden: An 87,721-Child Economic Study. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-eczema-germany-cost-illness-1291-routine-care 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-21.jpg?v=1794369311 Adult Eczema Cost of Illness in Germany: 1,291 People in Routine Care AI-created editorial illustration for Adult Eczema Cost of Illness in Germany: 1,291 People in Routine Care. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/long-term-work-outcomes-230-workers-occupational-skin-disease 2026-11-10T19:55:12-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-18-work_outcome_230.png?v=1794369312 Long-Term Work Outcomes in 230 Workers With Occupational Skin Disease Dr. Arsy #003 Life in Motion editorial illustration: Long-Term Work Outcomes in 230 Workers With Occupational Skin Disease. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/eczema-spain-specialized-care-3036-patient-cost-study 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-22.jpg?v=1794369315 Eczema Costs in Spanish Specialized Care: A 3,036-Patient Study AI-created editorial illustration for Eczema Costs in Spanish Specialized Care: A 3,036-Patient Study. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/occupational-skin-disease-555-685-australian-healthcare-workers 2026-11-10T19:55:15-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-19-australian_hcw_685.png?v=1794369315 Occupational Skin Disease in 555 of 685 Australian Healthcare Workers Dr. Arsy #003 Life in Motion editorial illustration: Occupational Skin Disease in 555 of 685 Australian Healthcare Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/eczema-canada-burden-76-patient-cost-study 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-24.jpg?v=1794369316 Eczema Costs and Burden in Canada: A 76-Patient Study AI-created editorial illustration for Eczema Costs and Burden in Canada: A 76-Patient Study. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-eczema-japan-cost-illness-web-survey 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-23.jpg?v=1794369318 Adult Eczema Cost of Illness in Japan: A National Web Survey AI-created editorial illustration for Adult Eczema Cost of Illness in Japan: A National Web Survey. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/healing-lifestyle-factors-1491-occupational-hand-eczema-patients 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-20-prognosis_1491.png?v=1794369318 Healing and Lifestyle Factors in 1,491 Occupational Hand-Eczema Patients Dr. Arsy #003 Life in Motion editorial illustration: Healing and Lifestyle Factors in 1,491 Occupational Hand-Eczema Patients. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/eczema-korea-healthcare-use-270008-national-claims-study 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-26.jpg?v=1794369319 Eczema Healthcare Use in Korea: A 270,008-Person National Claims Study AI-created editorial illustration for Eczema Healthcare Use in Korea: A 270,008-Person National Claims Study. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/eczema-korea-economic-impact-32-patient-cost-analysis 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-25.jpg?v=1794369321 The Economic Impact of Eczema in Korea: A 32-Patient Cost Analysis AI-created editorial illustration for The Economic Impact of Eczema in Korea: A 32-Patient Cost Analysis. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/mild-moderate-eczema-uk-propensity-cost-study 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-27.jpg?v=1794369324 Mild-to-Moderate Eczema in the U.K.: A Propensity-Matched Cost Study AI-created editorial illustration for Mild-to-Moderate Eczema in the U.K.: A Propensity-Matched Cost Study. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/child-eczema-sweden-controlled-uncontrolled-costs 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-29.jpg?v=1794369325 Controlled and Uncontrolled Childhood Eczema Costs in Sweden AI-created editorial illustration for Controlled and Uncontrolled Childhood Eczema Costs in Sweden. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-moderate-severe-eczema-denmark-societal-costs-5245 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-28.jpg?v=1794369327 Societal Costs of Adult Moderate-to-Severe Eczema in Denmark AI-created editorial illustration for Societal Costs of Adult Moderate-to-Severe Eczema in Denmark. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pediatric-eczema-economic-humanistic-burden-101-patient-study 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-30.jpg?v=1794369329 Pediatric Eczema Economic and Humanistic Burden: A 101-Patient Study AI-created editorial illustration for Pediatric Eczema Economic and Humanistic Burden: A 101-Patient Study. Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/child-facial-eczema-hydrocortisone-cream-safety-questions 2026-11-11T00:28:06-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/exec-a3e28b14-0724-4639-9e79-030e4b9e4793.png?v=1794371938 Can You Use Hydrocortisone on a Child’s Face for Eczema? AI-generated illustration of a family discussing a skin treatment with a pediatric clinician https://www.drarsy.com/blogs/news/pediatric-tacrolimus-180-child-vehicle-dose-trial 2026-11-10T21:14:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-tacrolimus-180-child-vehicle-dose-trial.jpg?v=1794374055 Pediatric Tacrolimus Ointment: A 180-Child Vehicle-Controlled Dose Trial AI-created research illustration for Pediatric tacrolimus dose-ranging trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/tacrolimus-mild-moderate-eczema-617-adult-child-trials 2026-11-10T21:14:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-mild-moderate-eczema-617-adult-child-trials.jpg?v=1794374068 Tacrolimus 0.03% for Mild-to-Moderate Eczema: Two Trials and 617 Patients AI-created research illustration for Tacrolimus trials in adults and children; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-tacrolimus-steroid-regimen-972-six-month-trial 2026-11-10T21:14:31-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-tacrolimus-steroid-regimen-972-six-month-trial.jpg?v=1794374071 Adult Tacrolimus Versus a Steroid Regimen: A 972-Patient Six-Month Trial AI-created research illustration for Adult tacrolimus versus steroid regimen; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-tacrolimus-steroid-regimen-80-one-year-trial 2026-11-10T21:14:34-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-tacrolimus-steroid-regimen-80-one-year-trial.jpg?v=1794374074 Adult Tacrolimus Versus Steroids: An 80-Person One-Year Trial AI-created research illustration for One-year adult topical comparison; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pimecrolimus-tacrolimus-141-child-tolerability-trial 2026-11-10T21:14:37-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-tacrolimus-141-child-tolerability-trial.jpg?v=1794374077 Pimecrolimus Versus Tacrolimus in 141 Children: Tolerability and Efficacy AI-created research illustration for Pimecrolimus versus tacrolimus tolerability; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pimecrolimus-713-child-one-year-flare-prevention-trial 2026-11-10T21:14:40-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-713-child-one-year-flare-prevention-trial.jpg?v=1794374080 Pimecrolimus in 713 Children: A One-Year Flare-Prevention Trial AI-created research illustration for Pediatric pimecrolimus flare prevention; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-tacrolimus-632-vehicle-controlled-efficacy-trials 2026-11-10T21:14:43-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-tacrolimus-632-vehicle-controlled-efficacy-trials.jpg?v=1794374083 Adult Tacrolimus Ointment: Two Vehicle-Controlled Trials in 632 People AI-created research illustration for Adult tacrolimus vehicle-controlled trials; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/child-tacrolimus-hydrocortisone-560-randomized-trial 2026-11-10T21:14:46-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-tacrolimus-hydrocortisone-560-randomized-trial.jpg?v=1794374086 Tacrolimus Versus Hydrocortisone in 560 Children With Eczema AI-created research illustration for Pediatric tacrolimus versus hydrocortisone; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-pimecrolimus-192-six-month-flare-prevention-study 2026-11-10T21:14:49-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-pimecrolimus-192-six-month-flare-prevention-study.jpg?v=1794374089 Adult Pimecrolimus: A 192-Person Six-Month Flare-Prevention Study AI-created research illustration for Adult pimecrolimus flare prevention; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/topical-eczema-treatments-219-trial-network-meta-analysis 2026-11-10T21:14:52-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-eczema-treatments-219-trial-network-meta-analysis.jpg?v=1794374091 Topical Eczema Treatments: A 219-Trial Network Meta-Analysis AI-created research illustration for Topical treatment network meta-analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/infant-pimecrolimus-186-vehicle-controlled-trial 2026-11-10T21:14:55-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/infant-pimecrolimus-186-vehicle-controlled-trial.jpg?v=1794374095 Pimecrolimus in 186 Infants: A Vehicle-Controlled Trial AI-created research illustration for Infant pimecrolimus vehicle-controlled trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/child-pimecrolimus-403-two-vehicle-controlled-trials 2026-11-10T21:15:04-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-pimecrolimus-403-two-vehicle-controlled-trials.jpg?v=1794374104 Pimecrolimus in 403 Children: Two Vehicle-Controlled Trials AI-created research illustration for Two pediatric pimecrolimus trials; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pimecrolimus-961-infant-child-one-year-pooled-analysis 2026-11-10T21:15:07-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-961-infant-child-one-year-pooled-analysis.jpg?v=1794374107 Pimecrolimus in 961 Infants and Children: A One-Year Pooled Analysis AI-created research illustration for One-year pooled pediatric pimecrolimus evidence; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pimecrolimus-vehicle-13-trial-meta-analysis-4180 2026-11-10T21:15:10-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-vehicle-13-trial-meta-analysis-4180.jpg?v=1794374110 Pimecrolimus Versus Vehicle: A 13-Trial, 4,180-Patient Meta-Analysis AI-created research illustration for Pimecrolimus meta-analysis of 13 trials; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pimecrolimus-sensitive-skin-27-trial-meta-analysis 2026-11-10T21:15:13-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-sensitive-skin-27-trial-meta-analysis.jpg?v=1794374113 Pimecrolimus for Children and Sensitive Skin: A 27-Trial Meta-Analysis AI-created research illustration for Pimecrolimus for children and sensitive skin; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/tacrolimus-7923-adult-child-open-label-study 2026-11-10T21:15:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-7923-adult-child-open-label-study.jpg?v=1794374116 Tacrolimus Ointment in 7,923 Adults and Children: An Open-Label Study AI-created research illustration for Large tacrolimus open-label study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/tacrolimus-canada-240-six-month-open-label-study 2026-11-10T21:15:19-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-canada-240-six-month-open-label-study.jpg?v=1794374118 Tacrolimus in Canada: A 240-Person, Six-Month Open-Label Study AI-created research illustration for Canadian tacrolimus open-label study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/tacrolimus-quality-life-985-adult-child-trial-analysis 2026-11-10T21:15:21-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-quality-life-985-adult-child-trial-analysis.jpg?v=1794374121 Tacrolimus and Quality of Life: Evidence From 985 Adults and Children AI-created research illustration for Tacrolimus quality-of-life analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/child-tacrolimus-fluticasone-479-noninferiority-trial 2026-11-10T21:15:24-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-tacrolimus-fluticasone-479-noninferiority-trial.jpg?v=1794374124 Tacrolimus Versus Fluticasone in 479 Children: A Noninferiority Trial AI-created research illustration for Pediatric tacrolimus versus fluticasone trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/child-tacrolimus-466-long-term-safety-study 2026-11-10T21:15:27-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-tacrolimus-466-long-term-safety-study.jpg?v=1794374127 Long-Term Tacrolimus in 466 Children: Safety and Efficacy AI-created research illustration for Long-term tacrolimus safety in children; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/tacrolimus-pharmacokinetics-adult-child-12-trial-analysis 2026-11-10T21:15:30-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-pharmacokinetics-adult-child-12-trial-analysis.jpg?v=1794374130 Tacrolimus Pharmacokinetics Across Adult and Pediatric Eczema Studies AI-created research illustration for Tacrolimus pharmacokinetics across studies; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/child-tacrolimus-pharmacokinetics-39-person-study 2026-11-10T21:15:40-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-tacrolimus-pharmacokinetics-39-person-study.jpg?v=1794374140 Tacrolimus Pharmacokinetics in 39 Children With Eczema AI-created research illustration for Pediatric tacrolimus pharmacokinetics; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/adult-tacrolimus-skin-blood-pharmacokinetics-14-study 2026-11-10T21:15:42-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-tacrolimus-skin-blood-pharmacokinetics-14-study.jpg?v=1794374142 Tacrolimus in Skin and Blood: A 14-Adult Pharmacokinetic Study AI-created research illustration for Tacrolimus in skin and blood; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/infant-tacrolimus-pharmacokinetics-53-once-twice-daily-study 2026-11-10T21:15:46-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/infant-tacrolimus-pharmacokinetics-53-once-twice-daily-study.jpg?v=1794374146 Tacrolimus Pharmacokinetics in 53 Infants: Once- Versus Twice-Daily Use AI-created research illustration for Infant tacrolimus dosing pharmacokinetics; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pimecrolimus-tacrolimus-pharmacokinetics-37-adult-comparison 2026-11-10T21:15:49-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-tacrolimus-pharmacokinetics-37-adult-comparison.jpg?v=1794374148 Pimecrolimus Versus Tacrolimus Systemic Exposure in 37 Adults AI-created research illustration for Pimecrolimus versus tacrolimus systemic exposure; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/infant-pimecrolimus-absorption-22-person-study 2026-11-10T21:15:52-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/infant-pimecrolimus-absorption-22-person-study.jpg?v=1794374152 Pimecrolimus Absorption in 22 Infants With Extensive Eczema AI-created research illustration for Pimecrolimus absorption in infants; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/eczema-lymphoma-topical-treatment-24-study-meta-analysis 2026-11-10T21:15:55-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/eczema-lymphoma-topical-treatment-24-study-meta-analysis.jpg?v=1794374155 Eczema, Lymphoma and Topical Treatment: A 24-Study Meta-Analysis AI-created research illustration for Eczema lymphoma and topical treatment evidence; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/tacrolimus-cutaneous-infections-1554-patient-analysis 2026-11-10T21:15:58-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-cutaneous-infections-1554-patient-analysis.jpg?v=1794374157 Tacrolimus and Cutaneous Infections: A 1,554-Patient Analysis AI-created research illustration for Tacrolimus cutaneous infection analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/tacrolimus-meningococcal-vaccine-response-232-child-trial 2026-11-10T21:16:00-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-meningococcal-vaccine-response-232-child-trial.jpg?v=1794374160 Tacrolimus and Meningococcal Vaccine Response: A 232-Child Trial AI-created research illustration for Tacrolimus and pediatric vaccine response; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/tacrolimus-cancer-incidence-7954-child-apples-cohort 2026-11-10T21:16:03-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-cancer-incidence-7954-child-apples-cohort.jpg?v=1794374163 Tacrolimus and Cancer Incidence: The 7,954-Child APPLES Cohort AI-created research illustration for Long-term pediatric tacrolimus cohort; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/occupational-contact-dermatitis-1255-healthcare-workers-15896-patients 2026-11-10T21:43:56-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-01-hcw_nacdg_1255.png?v=1794375835 Occupational Contact Dermatitis in 1,255 Healthcare Workers From 15,896 Patch-Tested Patients Dr. Arsy #003 Life in Motion editorial illustration: Occupational Contact Dermatitis in 1,255 Healthcare Workers From 15,896 Patch-Tested Patients. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/skin-disease-4000-workers-104-greek-enterprises 2026-11-10T21:43:59-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-05-greek_enterprises_4000.png?v=1794375839 Skin Disease Across 4,000 Workers in 104 Greek Enterprises Dr. Arsy #003 Life in Motion editorial illustration: Skin Disease Across 4,000 Workers in 104 Greek Enterprises. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/occupational-skin-disease-incidence-uk-specialists-2002-2005 2026-11-10T21:44:01-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-03-thor_2002_2005.png?v=1794375841 Occupational Skin-Disease Incidence Reported by UK Specialists, 2002–2005 Dr. Arsy #003 Life in Motion editorial illustration: Occupational Skin-Disease Incidence Reported by UK Specialists, 2002–2005. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/dermatitis-patch-tests-21-300-polyurethane-foam-workers 2026-11-10T21:44:04-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-04-polyurethane_foam_300.png?v=1794375844 Dermatitis and Patch Tests in 21 of 300 Polyurethane-Foam Workers Dr. Arsy #003 Life in Motion editorial illustration: Dermatitis and Patch Tests in 21 of 300 Polyurethane-Foam Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/skin-airway-allergy-2413-finnish-occupational-disease-cases 2026-11-10T21:44:07-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-02-frod_skin_airway_2413.png?v=1794375847 Skin and Airway Allergy Across 2,413 Finnish Occupational-Disease Cases Dr. Arsy #003 Life in Motion editorial illustration: Skin and Airway Allergy Across 2,413 Finnish Occupational-Disease Cases. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/examining-757-finnish-machinists-occupational-dermatoses 2026-11-10T21:44:10-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-06-finnish_machinists_961.png?v=1794375850 Examining 757 Finnish Machinists for Occupational Dermatoses Dr. Arsy #003 Life in Motion editorial illustration: Examining 757 Finnish Machinists for Occupational Dermatoses. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/mci-mi-dermatitis-outbreak-8-15-water-bottle-workers 2026-11-10T21:44:13-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-09-water_bottle_mci_15.png?v=1794375853 MCI/MI Dermatitis Outbreak in 8 of 15 Water-Bottle Plant Workers Dr. Arsy #003 Life in Motion editorial illustration: MCI/MI Dermatitis Outbreak in 8 of 15 Water-Bottle Plant Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/five-years-uk-occupational-skin-disease-reports 2026-11-10T21:44:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-07-uk_epiderm_opra_1996_2001.png?v=1794375856 Five Years of UK Occupational Skin-Disease Reports Dr. Arsy #003 Life in Motion editorial illustration: Five Years of UK Occupational Skin-Disease Reports. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/six-years-epiderm-opra-occupational-skin-surveillance 2026-11-10T21:44:19-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-08-epiderm_opra_six_years.png?v=1794375859 Six Years of EPIDERM and OPRA Occupational-Skin Surveillance Dr. Arsy #003 Life in Motion editorial illustration: Six Years of EPIDERM and OPRA Occupational-Skin Surveillance. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/smartphone-glue-dermatitis-13-screen-protector-workers 2026-11-10T21:44:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-10-screen_glue_13.png?v=1794375862 Smartphone-Glue Dermatitis in 13 Screen-Protector Workers Dr. Arsy #003 Life in Motion editorial illustration: Smartphone-Glue Dermatitis in 13 Screen-Protector Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/sealant-dermatitis-12-48-refrigerator-factory-workers 2026-11-10T21:44:25-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-11-sealant_48.png?v=1794375865 Sealant Dermatitis in 12 of 48 Refrigerator-Factory Workers Dr. Arsy #003 Life in Motion editorial illustration: Sealant Dermatitis in 12 of 48 Refrigerator-Factory Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/phenol-formaldehyde-dermatitis-two-plywood-mill-workers 2026-11-10T21:44:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-13-plywood_resin_2.png?v=1794375868 Phenol-Formaldehyde Dermatitis in Two Plywood-Mill Workers Dr. Arsy #003 Life in Motion editorial illustration: Phenol-Formaldehyde Dermatitis in Two Plywood-Mill Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/isocyanate-allergy-investigation-seven-heat-exchanger-workers 2026-11-10T21:44:30-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-12-isocyanate_heat_exchanger_7.png?v=1794375870 Isocyanate-Allergy Investigation in Seven Heat-Exchanger Workers Dr. Arsy #003 Life in Motion editorial illustration: Isocyanate-Allergy Investigation in Seven Heat-Exchanger Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/training-gaps-100-workers-hand-dermatitis 2026-11-10T21:44:33-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-15-training_hand_dermatitis_100.png?v=1794375873 Training Gaps Among 100 Workers With Hand Dermatitis Dr. Arsy #003 Life in Motion editorial illustration: Training Gaps Among 100 Workers With Hand Dermatitis. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/769-recognized-occupational-skin-cases-french-cleaning-work 2026-11-10T21:44:36-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-14-french_cleaning_769.png?v=1794375876 769 Recognized Occupational-Skin Cases in French Cleaning Work Dr. Arsy #003 Life in Motion editorial illustration: 769 Recognized Occupational-Skin Cases in French Cleaning Work. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/glove-allergy-16-operating-theatre-workers 2026-11-10T21:44:39-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-17-sterile_gloves_16.png?v=1794375879 Glove Allergy in 16 Operating-Theatre Workers Dr. Arsy #003 Life in Motion editorial illustration: Glove Allergy in 16 Operating-Theatre Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/concurrent-skin-respiratory-symptoms-204-referred-workers 2026-11-10T21:44:41-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-16-skin_respiratory_204.png?v=1794375881 Concurrent Skin and Respiratory Symptoms in 204 Referred Workers Dr. Arsy #003 Life in Motion editorial illustration: Concurrent Skin and Respiratory Symptoms in 204 Referred Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/epoxy-reaction-investigation-25-carbon-fibre-workers 2026-11-10T21:44:44-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-18-carbon_epoxy_25.png?v=1794375884 Epoxy-Reaction Investigation in 25 Carbon-Fibre Workers Dr. Arsy #003 Life in Motion editorial illustration: Epoxy-Reaction Investigation in 25 Carbon-Fibre Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/chromate-amine-allergy-24-precast-concrete-workers 2026-11-10T21:44:47-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-19-precast_concrete_24.png?v=1794375887 Chromate and Amine Allergy in 24 Precast-Concrete Workers Dr. Arsy #003 Life in Motion editorial illustration: Chromate and Amine Allergy in 24 Precast-Concrete Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/7445-washington-workers-compensation-skin-claims 2026-11-10T21:44:50-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-20-washington_claims_7445.png?v=1794375890 7,445 Washington Workers’ Compensation Skin Claims Dr. Arsy #003 Life in Motion editorial illustration: 7,445 Washington Workers’ Compensation Skin Claims. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/slugging-facial-eczema-occlusive-moisturizer-safety 2026-11-11T00:28:06-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/exec-9e5c4ffc-0ad7-410b-ab50-623dafe99d73.png?v=1794375939 Slugging for Facial Eczema: Does Sealing In Moisture Help? AI-generated illustration of an adult discussing a facial moisturizing routine with a dermatologist https://www.drarsy.com/blogs/news/crisaborole-maximal-use-34-child-pharmacokinetic-study 2026-11-10T21:59:08-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-maximal-use-34-child-pharmacokinetic-study.jpg?v=1794376748 Crisaborole Under Maximal-Use Conditions: A 34-Child Pharmacokinetic Study AI-created research illustration for Crisaborole Under Maximal-Use Conditions: A 34-Child Pharmacokinetic Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/proactive-crisaborole-142-child-randomized-trial 2026-11-10T21:59:10-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/proactive-crisaborole-142-child-randomized-trial.jpg?v=1794376750 Proactive Crisaborole in 142 Children: A 16-Week Randomized Trial AI-created research illustration for Proactive Crisaborole in 142 Children: A 16-Week Randomized Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-once-daily-270-patient-52-week-maintenance 2026-11-10T21:59:12-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-once-daily-270-patient-52-week-maintenance.jpg?v=1794376752 Once-Daily Crisaborole Maintenance: A 270-Patient, 52-Week Trial AI-created research illustration for Once-Daily Crisaborole Maintenance: A 270-Patient, 52-Week Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-adult-biomarker-40-person-intrapatient-trial 2026-11-10T21:59:14-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-adult-biomarker-40-person-intrapatient-trial.jpg?v=1794376753 Crisaborole Skin Biomarkers: A 40-Adult Intrapatient Randomized Trial AI-created research illustration for Crisaborole Skin Biomarkers: A 40-Adult Intrapatient Randomized Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pediatric-topical-pde4-five-rct-1877-meta-analysis 2026-11-10T21:59:15-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-topical-pde4-five-rct-1877-meta-analysis.jpg?v=1794376755 Topical PDE4 Inhibitors in 1,877 Children: A Five-Trial Meta-Analysis AI-created research illustration for Topical PDE4 Inhibitors in 1,877 Children: A Five-Trial Meta-Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/thailand-crisaborole-90-child-real-world-study 2026-11-10T21:59:17-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/thailand-crisaborole-90-child-real-world-study.jpg?v=1794376757 Crisaborole in Thailand: A 90-Child Real-World Study AI-created research illustration for Crisaborole in Thailand: A 90-Child Real-World Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-517-patient-48-week-long-term-safety-study 2026-11-10T21:59:19-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-517-patient-48-week-long-term-safety-study.jpg?v=1794376759 Crisaborole Long-Term Safety: A 517-Patient, 48-Week Study AI-created research illustration for Crisaborole Long-Term Safety: A 517-Patient, 48-Week Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-topical-treatment-network-meta-analysis 2026-11-10T21:59:21-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-topical-treatment-network-meta-analysis.jpg?v=1794376761 Crisaborole in a Topical-Treatment Network Meta-Analysis AI-created research illustration for Crisaborole in a Topical-Treatment Network Meta-Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/difamilast-73-child-phase2-dose-ranging-trial 2026-11-10T21:59:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/difamilast-73-child-phase2-dose-ranging-trial.jpg?v=1794376763 Difamilast in 73 Children: A Phase 2 Dose-Ranging Trial AI-created research illustration for Difamilast in 73 Children: A Phase 2 Dose-Ranging Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/roflumilast-652-child-age2-5-integument-ped-trial 2026-11-10T21:59:25-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/roflumilast-652-child-age2-5-integument-ped-trial.jpg?v=1794376765 Roflumilast Cream in 652 Children Ages 2–5: INTEGUMENT-PED AI-created research illustration for Roflumilast Cream in 652 Children Ages 2–5: INTEGUMENT-PED; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-137-infant-crisade-care1-study 2026-11-10T21:59:27-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-137-infant-crisade-care1-study.jpg?v=1794376767 Crisaborole in 137 Infants: The CrisADe CARE 1 Study AI-created research illustration for Crisaborole in 137 Infants: The CrisADe CARE 1 Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/topical-pde4-seven-study-1869-person-meta-analysis 2026-11-10T21:59:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-pde4-seven-study-1869-person-meta-analysis.jpg?v=1794376769 Topical PDE4 Inhibitors: A Seven-Study, 1,869-Person Meta-Analysis AI-created research illustration for Topical PDE4 Inhibitors: A Seven-Study, 1,869-Person Meta-Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/difamilast-121-adult-adolescent-phase2-trial 2026-11-10T21:59:31-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/difamilast-121-adult-adolescent-phase2-trial.jpg?v=1794376770 Difamilast in 121 Adults and Adolescents: A Phase 2 Trial AI-created research illustration for Difamilast in 121 Adults and Adolescents: A Phase 2 Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-pruritus-qol-mediation-analysis-1522 2026-11-10T21:59:32-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-pruritus-qol-mediation-analysis-1522.jpg?v=1794376772 How Itch Mediated Quality of Life in Crisaborole Trials AI-created research illustration for How Itch Mediated Quality of Life in Crisaborole Trials; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-quality-life-1522-phase3-pooled-study 2026-11-10T21:59:34-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-quality-life-1522-phase3-pooled-study.jpg?v=1794376774 Crisaborole and Quality of Life: A Pooled Phase 3 Analysis AI-created research illustration for Crisaborole and Quality of Life: A Pooled Phase 3 Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-pruritus-quality-life-1522-longitudinal-analysis 2026-11-10T21:59:36-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-pruritus-quality-life-1522-longitudinal-analysis.jpg?v=1794376776 Itch and Quality of Life in 1,522 Crisaborole-Trial Participants AI-created research illustration for Itch and Quality of Life in 1,522 Crisaborole-Trial Participants; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-adsi-body-surface-area-1522-pooled-analysis 2026-11-10T21:59:38-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-adsi-body-surface-area-1522-pooled-analysis.jpg?v=1794376778 Crisaborole, ADSI and Body Surface Area: A 1,522-Patient Analysis AI-created research illustration for Crisaborole, ADSI and Body Surface Area: A 1,522-Patient Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-application-site-pain-retrospective-study 2026-11-10T22:00:11-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-application-site-pain-retrospective-study.jpg?v=1794376811 Application-Site Pain With Crisaborole: A Retrospective Study AI-created research illustration for Application-Site Pain With Crisaborole: A Retrospective Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/israel-crisaborole-441-real-world-patient-study 2026-11-10T22:00:13-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/israel-crisaborole-441-real-world-patient-study.jpg?v=1794376813 Early Crisaborole Users in Israel: A 441-Patient Database Study AI-created research illustration for Early Crisaborole Users in Israel: A 441-Patient Database Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-contact-allergy-child-case-report 2026-11-10T22:00:15-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-contact-allergy-child-case-report.jpg?v=1794376815 Contact Allergy to Crisaborole in a Child: A Case Report AI-created research illustration for Contact Allergy to Crisaborole in a Child: A Case Report; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/difamilast-41-infant-52-week-open-label-study 2026-11-10T22:00:18-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/difamilast-41-infant-52-week-open-label-study.jpg?v=1794376817 Difamilast in 41 Infants: A 52-Week Open-Label Study AI-created research illustration for Difamilast in 41 Infants: A 52-Week Open-Label Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-pediatric-baseline-severity-pruritus-analysis 2026-11-10T22:00:20-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-pediatric-baseline-severity-pruritus-analysis.jpg?v=1794376820 Crisaborole by Baseline Severity: Pediatric Itch and Disease Outcomes AI-created research illustration for Crisaborole by Baseline Severity: Pediatric Itch and Disease Outcomes; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-1313-child-subgroup-analysis 2026-11-10T22:00:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-1313-child-subgroup-analysis.jpg?v=1794376821 Crisaborole Across Pediatric Subgroups: A 1,313-Child Analysis AI-created research illustration for Crisaborole Across Pediatric Subgroups: A 1,313-Child Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-systemic-exposure-244-person-regression-study 2026-11-10T22:00:24-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-systemic-exposure-244-person-regression-study.jpg?v=1794376824 Predictors of Crisaborole Exposure: A 244-Person Regression Study AI-created research illustration for Predictors of Crisaborole Exposure: A 244-Person Regression Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pediatric-topical-eczema-medication-safety-75-study-review 2026-11-10T22:00:26-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-topical-eczema-medication-safety-75-study-review.jpg?v=1794376826 Pediatric Topical Eczema Safety: A 75-Study Systematic Review AI-created research illustration for Pediatric Topical Eczema Safety: A 75-Study Systematic Review; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-clinical-development-pde4-review 2026-11-10T22:00:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-clinical-development-pde4-review.jpg?v=1794376828 Crisaborole Clinical Development: From PDE4 Biology to Phase 3 AI-created research illustration for Crisaborole Clinical Development: From PDE4 Biology to Phase 3; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-adult-phase2a-vehicle-controlled-proof-concept 2026-11-10T22:00:31-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-adult-phase2a-vehicle-controlled-proof-concept.jpg?v=1794376831 Crisaborole in 25 Adults: A Bilateral Phase 2a Proof-of-Concept Study AI-created research illustration for Crisaborole in 25 Adults: A Bilateral Phase 2a Proof-of-Concept Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/e6005-40-adult-dose-ranging-pde4-trial 2026-11-10T22:00:33-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/e6005-40-adult-dose-ranging-pde4-trial.jpg?v=1794376833 E6005 Ointment in 40 Adults: A Dose-Ranging PDE4 Trial AI-created research illustration for E6005 Ointment in 40 Adults: A Dose-Ranging PDE4 Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/oral-apremilast-185-adult-eczema-phase2-trial 2026-11-10T22:00:35-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/oral-apremilast-185-adult-eczema-phase2-trial.jpg?v=1794376835 Oral Apremilast in 185 Adults: A Phase 2 Eczema Trial AI-created research illustration for Oral Apremilast in 185 Adults: A Phase 2 Eczema Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/apremilast-cyclosporine-50-adult-randomized-study 2026-11-10T22:00:38-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/apremilast-cyclosporine-50-adult-randomized-study.jpg?v=1794376837 Apremilast Versus Cyclosporine: A 50-Adult Randomized Study AI-created research illustration for Apremilast Versus Cyclosporine: A 50-Adult Randomized Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/contact-dermatitis-8-17-paint-factory-workers-acticide-ep 2026-11-10T22:47:39-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-01.png?v=1794379659 Contact Dermatitis in 8 of 17 Paint-Factory Workers Exposed to Acticide EP Dr. Arsy #003 Life in Motion editorial illustration: Contact Dermatitis in 8 of 17 Paint-Factory Workers Exposed to Acticide EP. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/isocyanate-lacquer-allergy-five-laminate-board-workers 2026-11-10T22:47:42-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-02.png?v=1794379662 Isocyanate-Lacquer Allergy Investigation in Five Laminate-Board Workers Dr. Arsy #003 Life in Motion editorial illustration: Isocyanate-Lacquer Allergy Investigation in Five Laminate-Board Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/particleboard-factory-dermatitis-investigation-new-process 2026-11-10T22:56:33-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-03.png?v=1794379665 What a Particleboard-Factory Investigation Found After a New Process Dr. Arsy #003 Life in Motion editorial illustration: What a Particleboard-Factory Investigation Found After a New Process. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/occupational-dermatoses-603-epoxy-rotor-blade-workers 2026-11-10T22:47:48-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-07.png?v=1794379668 Occupational Dermatoses in 603 Epoxy Rotor-Blade Workers Dr. Arsy #003 Life in Motion editorial illustration: Occupational Dermatoses in 603 Epoxy Rotor-Blade Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/skin-disease-426-pesticide-authorized-farm-workers-100-controls 2026-11-10T22:47:51-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-06.png?v=1794379671 Skin Disease in 426 Pesticide-Authorized Farm Workers Versus 100 Controls Dr. Arsy #003 Life in Motion editorial illustration: Skin Disease in 426 Pesticide-Authorized Farm Workers Versus 100 Controls. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/dibutyl-maleate-dermatitis-10-20-envelope-factory-workers 2026-11-10T22:47:54-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-09.png?v=1794379674 Dibutyl-Maleate Dermatitis in 10 of 20 Envelope-Factory Workers Dr. Arsy #003 Life in Motion editorial illustration: Dibutyl-Maleate Dermatitis in 10 of 20 Envelope-Factory Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/oil-acne-dermatitis-159-building-materials-workers 2026-11-10T22:47:57-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-08.png?v=1794379677 Oil Acne and Dermatitis Findings in 159 Building-Materials Workers Dr. Arsy #003 Life in Motion editorial illustration: Oil Acne and Dermatitis Findings in 159 Building-Materials Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/contact-dermatitis-ten-spanish-wind-energy-workers 2026-11-10T22:48:00-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-04.png?v=1794379680 Contact Dermatitis Findings in Ten Spanish Wind-Energy Workers Dr. Arsy #003 Life in Motion editorial illustration: Contact Dermatitis Findings in Ten Spanish Wind-Energy Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/skin-findings-341-south-indian-paddy-field-workers 2026-11-10T22:48:03-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-05.png?v=1794379683 Skin Findings Across 341 South Indian Paddy-Field Workers Dr. Arsy #003 Life in Motion editorial illustration: Skin Findings Across 341 South Indian Paddy-Field Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/skin-symptoms-70-spice-factory-workers-23-office-staff 2026-11-10T22:48:07-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-10.png?v=1794379686 Skin Symptoms in 70 Spice-Factory Workers and 23 Office Staff Dr. Arsy #003 Life in Motion editorial illustration: Skin Symptoms in 70 Spice-Factory Workers and 23 Office Staff. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/uv-curing-resin-dermatitis-industrial-homeworker-case 2026-11-10T22:48:09-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-11.png?v=1794379689 UV-Curing Resin Dermatitis in One Industrial Homeworker Dr. Arsy #003 Life in Motion editorial illustration: UV-Curing Resin Dermatitis in One Industrial Homeworker. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/kathon-occupational-dermatitis-milk-industry-worker 2026-11-10T22:48:12-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-12.png?v=1794379692 Kathon-Related Occupational Dermatitis in a Milk-Industry Worker Dr. Arsy #003 Life in Motion editorial illustration: Kathon-Related Occupational Dermatitis in a Milk-Industry Worker. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/eptmac-hand-dermatitis-four-starch-process-workers 2026-11-10T22:48:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-13.png?v=1794379695 EPTMAC Hand Dermatitis in Four Starch-Process Workers Dr. Arsy #003 Life in Motion editorial illustration: EPTMAC Hand Dermatitis in Four Starch-Process Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/epoxy-dermatitis-eight-130-fiberglass-workers 2026-11-10T22:48:19-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-14.png?v=1794379698 Epoxy Dermatitis in Eight of About 130 Fiberglass Workers Dr. Arsy #003 Life in Motion editorial illustration: Epoxy Dermatitis in Eight of About 130 Fiberglass Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/facial-eczema-makeup-brushes-cleaning-sensitive-skin 2026-11-11T00:28:11-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/exec-f81f6c86-e0c1-4ca9-8026-6948d4bd672e.png?v=1794379701 Facial Eczema and Makeup Brushes: A Gentle Hygiene Routine AI-generated illustration of makeup brushes drying on a clean towel https://www.drarsy.com/blogs/news/occupational-dermatoses-binder-plant-83-current-12-former-workers 2026-11-10T22:48:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-17.png?v=1794379702 Occupational Dermatoses in a Binder Plant: 83 Current and 12 Former Workers Dr. Arsy #003 Life in Motion editorial illustration: Occupational Dermatoses in a Binder Plant: 83 Current and 12 Former Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/contact-dermatitis-45-semisynthetic-penicillin-factory-workers 2026-11-10T22:48:25-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-15.png?v=1794379704 Contact Dermatitis in 45 Semisynthetic-Penicillin Factory Workers Dr. Arsy #003 Life in Motion editorial illustration: Contact Dermatitis in 45 Semisynthetic-Penicillin Factory Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/occupational-colophonium-allergy-39-patients 2026-11-10T22:48:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-16.png?v=1794379708 Occupational Colophonium Allergy in 39 Clinically Diagnosed Patients Dr. Arsy #003 Life in Motion editorial illustration: Occupational Colophonium Allergy in 39 Clinically Diagnosed Patients. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/methylisothiazolinone-contact-allergy-four-14-paint-workers 2026-11-10T22:48:31-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-18.png?v=1794379711 Methylisothiazolinone Contact Allergy in Four of 14 Paint-Factory Workers Dr. Arsy #003 Life in Motion editorial illustration: Methylisothiazolinone Contact Allergy in Four of 14 Paint-Factory Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/isocyanate-allergy-16-medical-equipment-factory-workers 2026-11-10T22:48:34-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-19.png?v=1794379714 Isocyanate Allergy in 16 Medical-Equipment Factory Workers Dr. Arsy #003 Life in Motion editorial illustration: Isocyanate Allergy in 16 Medical-Equipment Factory Workers. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/resin-dermatitis-50-car-assembly-workers-weatherstrips 2026-11-10T22:48:37-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-20.png?v=1794379717 Resin Dermatitis in 50 Car-Assembly Workers Handling Coated Weatherstrips Dr. Arsy #003 Life in Motion editorial illustration: Resin Dermatitis in 50 Car-Assembly Workers Handling Coated Weatherstrips. Fictional scene; not a patient or treatment result. https://www.drarsy.com/blogs/news/ati1777-topical-jak1-3-48-adult-phase2a-trial 2026-11-10T23:05:38-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ati1777-topical-jak1-3-48-adult-phase2a-trial.jpg?v=1794380738 ATI-1777 Topical JAK1/3 Inhibition: A 48-Adult Phase 2a Trial AI-created research illustration for ATI-1777 Topical JAK1/3 Inhibition: A 48-Adult Phase 2a Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/topical-tofacitinib-69-adult-phase2a-randomized-trial 2026-11-10T23:05:40-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-tofacitinib-69-adult-phase2a-randomized-trial.jpg?v=1794380740 Topical Tofacitinib in 69 Adults: A Phase 2a Randomized Trial AI-created research illustration for Topical Tofacitinib in 69 Adults: A Phase 2a Randomized Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/delgocitinib-children-2-15-phase2-dose-trial 2026-11-10T23:05:42-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-children-2-15-phase2-dose-trial.jpg?v=1794380742 Delgocitinib in Children Ages 2–15: A Phase 2 Dose Trial AI-created research illustration for Delgocitinib in Children Ages 2–15: A Phase 2 Dose Trial; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/delgocitinib-adult-phase3-28-week-extension-study 2026-11-10T23:05:44-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-adult-phase3-28-week-extension-study.jpg?v=1794380743 Delgocitinib in Adults: A Phase 3 Trial and 28-Week Extension AI-created research illustration for Delgocitinib in Adults: A Phase 3 Trial and 28-Week Extension; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/delgocitinib-pediatric-phase3-56-week-long-term-study 2026-11-10T23:05:45-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-pediatric-phase3-56-week-long-term-study.jpg?v=1794380745 Delgocitinib in Children: A Phase 3 Trial and 56-Week Study AI-created research illustration for Delgocitinib in Children: A Phase 3 Trial and 56-Week Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/jte052-delgocitinib-phase1-phototoxicity-pk-study 2026-11-10T23:05:47-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/jte052-delgocitinib-phase1-phototoxicity-pk-study.jpg?v=1794380747 JTE-052 Phase 1 Studies: Skin Safety and Pharmacokinetics AI-created research illustration for JTE-052 Phase 1 Studies: Skin Safety and Pharmacokinetics; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/jte052-327-adult-dose-ranging-tacrolimus-reference-trial 2026-11-10T23:05:49-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/jte052-327-adult-dose-ranging-tacrolimus-reference-trial.jpg?v=1794380749 JTE-052 in 327 Adults: Dose Ranging With Tacrolimus Reference AI-created research illustration for JTE-052 in 327 Adults: Dose Ranging With Tacrolimus Reference; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/delgocitinib-506-adult-52-week-safety-study 2026-11-10T23:05:51-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-506-adult-52-week-safety-study.jpg?v=1794380751 Delgocitinib Long-Term Safety: A 506-Adult Pooled Analysis AI-created research illustration for Delgocitinib Long-Term Safety: A 506-Adult Pooled Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/delgocitinib-22-infant-52-week-open-label-study 2026-11-10T23:05:53-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-22-infant-52-week-open-label-study.jpg?v=1794380753 Delgocitinib in 22 Infants: A 52-Week Open-Label Study AI-created research illustration for Delgocitinib in 22 Infants: A 52-Week Open-Label Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/delgocitinib-pediatric-dose-severity-posthoc-analysis 2026-11-10T23:05:55-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-pediatric-dose-severity-posthoc-analysis.jpg?v=1794380755 Pediatric Delgocitinib by Dose and Severity: A Post Hoc Analysis AI-created research illustration for Pediatric Delgocitinib by Dose and Severity: A Post Hoc Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-cream-adolescents-pooled-52-week-analysis 2026-11-10T23:06:05-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-adolescents-pooled-52-week-analysis.jpg?v=1794380765 Ruxolitinib Cream in Adolescents: A Pooled 52-Week Analysis AI-created research illustration for Ruxolitinib Cream in Adolescents: A Pooled 52-Week Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-cream-1208-patient-reported-outcomes-analysis 2026-11-10T23:06:08-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-1208-patient-reported-outcomes-analysis.jpg?v=1794380768 Ruxolitinib Cream Patient-Reported Outcomes in 1,208 Participants AI-created research illustration for Ruxolitinib Cream Patient-Reported Outcomes in 1,208 Participants; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-103-adolescent-one-year-open-label-study 2026-11-10T23:06:10-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-103-adolescent-one-year-open-label-study.jpg?v=1794380770 Ruxolitinib Cream in 103 Adolescents: A One-Year Study AI-created research illustration for Ruxolitinib Cream in 103 Adolescents: A One-Year Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-71-child-adolescent-phase1-pk-study 2026-11-10T23:06:12-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-71-child-adolescent-phase1-pk-study.jpg?v=1794380772 Ruxolitinib Cream in 71 Young Patients: A Phase 1 PK Study AI-created research illustration for Ruxolitinib Cream in 71 Young Patients: A Phase 1 PK Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-cream-phase2-3-population-pk-analysis 2026-11-10T23:06:14-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-phase2-3-population-pk-analysis.jpg?v=1794380774 Ruxolitinib Cream Pharmacokinetics Across Phase 2 and 3 Trials AI-created research illustration for Ruxolitinib Cream Pharmacokinetics Across Phase 2 and 3 Trials; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-cream-anatomic-regions-1208-pooled-analysis 2026-11-10T23:06:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-anatomic-regions-1208-pooled-analysis.jpg?v=1794380776 Ruxolitinib Cream Across Body Regions: A 1,208-Patient Analysis AI-created research illustration for Ruxolitinib Cream Across Body Regions: A 1,208-Patient Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-29-child-maximum-use-52-week-study 2026-11-10T23:06:18-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-29-child-maximum-use-52-week-study.jpg?v=1794380778 Ruxolitinib Cream Maximum Use in 29 Children: A 52-Week Study AI-created research illustration for Ruxolitinib Cream Maximum Use in 29 Children: A 52-Week Study; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-307-adult-itch-quality-life-phase2-analysis 2026-11-10T23:06:20-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-307-adult-itch-quality-life-phase2-analysis.jpg?v=1794380780 Ruxolitinib Cream, Itch and Quality of Life: A 307-Adult Analysis AI-created research illustration for Ruxolitinib Cream, Itch and Quality of Life: A 307-Adult Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-428-patient-as-needed-disease-control-analysis 2026-11-10T23:06:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-428-patient-as-needed-disease-control-analysis.jpg?v=1794380782 As-Needed Ruxolitinib Cream: Disease Control in 428 Patients AI-created research illustration for As-Needed Ruxolitinib Cream: Disease Control in 428 Patients; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-1031-patient-52-week-long-term-safety-analysis 2026-11-10T23:06:24-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-1031-patient-52-week-long-term-safety-analysis.jpg?v=1794380784 Ruxolitinib Cream Long-Term Safety: A 1,031-Patient Analysis AI-created research illustration for Ruxolitinib Cream Long-Term Safety: A 1,031-Patient Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-78-higher-severity-threshold-posthoc-analysis 2026-11-10T23:06:33-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-78-higher-severity-threshold-posthoc-analysis.jpg?v=1794380793 Ruxolitinib Cream in 78 Patients Meeting Higher-Severity Thresholds AI-created research illustration for Ruxolitinib Cream in 78 Patients Meeting Higher-Severity Thresholds; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-307-adult-dose-ranging-triamcinolone-reference-trial 2026-11-10T23:06:35-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-307-adult-dose-ranging-triamcinolone-reference-trial.jpg?v=1794380795 Ruxolitinib Cream in 307 Adults: Dose Ranging With Triamcinolone Reference AI-created research illustration for Ruxolitinib Cream in 307 Adults: Dose Ranging With Triamcinolone Reference; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-1249-patient-prior-treatment-posthoc-analysis 2026-11-10T23:06:37-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-1249-patient-prior-treatment-posthoc-analysis.jpg?v=1794380797 Ruxolitinib Cream by Prior Treatment: A 1,249-Patient Analysis AI-created research illustration for Ruxolitinib Cream by Prior Treatment: A 1,249-Patient Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/topical-jak-inhibitors-10-rct-safety-network-meta-analysis 2026-11-10T23:06:39-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-jak-inhibitors-10-rct-safety-network-meta-analysis.jpg?v=1794380799 Topical JAK Inhibitor Safety: A 10-Trial Network Meta-Analysis AI-created research illustration for Topical JAK Inhibitor Safety: A 10-Trial Network Meta-Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-cream-five-rct-1912-patient-meta-analysis 2026-11-10T23:06:41-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-five-rct-1912-patient-meta-analysis.jpg?v=1794380801 Ruxolitinib Cream: A Five-Trial, 1,912-Patient Meta-Analysis AI-created research illustration for Ruxolitinib Cream: A Five-Trial, 1,912-Patient Meta-Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pediatric-topical-jak-eight-study-541-patient-review 2026-11-10T23:06:43-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-topical-jak-eight-study-541-patient-review.jpg?v=1794380803 Pediatric Topical JAK Inhibitors: An Eight-Study, 541-Patient Review AI-created research illustration for Pediatric Topical JAK Inhibitors: An Eight-Study, 541-Patient Review; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/pediatric-nonsteroidal-topicals-network-meta-analysis-2026 2026-11-10T23:06:46-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-nonsteroidal-topicals-network-meta-analysis-2026.jpg?v=1794380805 Pediatric Nonsteroidal Topicals: A 2026 Network Meta-Analysis AI-created research illustration for Pediatric Nonsteroidal Topicals: A 2026 Network Meta-Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/topical-anti-inflammatory-291-trial-cochrane-network-analysis 2026-11-10T23:06:47-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-anti-inflammatory-291-trial-cochrane-network-analysis.jpg?v=1794380807 Topical Anti-Inflammatories: A 291-Trial Cochrane Network Analysis AI-created research illustration for Topical Anti-Inflammatories: A 291-Trial Cochrane Network Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/crisaborole-delgocitinib-ruxolitinib-17-study-meta-analysis 2026-11-10T23:06:49-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-delgocitinib-ruxolitinib-17-study-meta-analysis.jpg?v=1794380809 Three Newer Topicals: A 17-Study Safety and Efficacy Meta-Analysis AI-created research illustration for Three Newer Topicals: A 17-Study Safety and Efficacy Meta-Analysis; Dr. Arsy #003 was not the study product. https://www.drarsy.com/blogs/news/ruxolitinib-vs-systemic-12-study-network-meta-analysis 2026-11-10T23:06:51-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-vs-systemic-12-study-network-meta-analysis.jpg?v=1794380811 Ruxolitinib Cream Versus Systemic Agents: A 12-Study Network Analysis AI-created research illustration for Ruxolitinib Cream Versus Systemic Agents: A 12-Study Network Analysis; Dr. Arsy #003 was not the study product.